GLABF (Gemina Laboratories) Common Stock: $9.13 Mil (As of Oct. 2025)


What is Gemina Laboratories Common Stock?

Gemina Laboratories GLABF -27.59% Common Stock is $9.13 Mil as of Oct. 2025. The stock has 2 warning signs investors should review.

Gemina Laboratories's quarterly common stock increased from Apr. 2025 ($9.14 Mil) to Jul. 2025 ($9.33 Mil) but then declined from Jul. 2025 ($9.33 Mil) to Oct. 2025 ($9.13 Mil).

Gemina Laboratories's annual common stock increased from Jan. 2023 ($6.07 Mil) to Jan. 2024 ($8.37 Mil) but then declined from Jan. 2024 ($8.37 Mil) to Jan. 2025 ($8.33 Mil).

Gemina Laboratories Common Stock Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Common Stock Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Common Stock
0.78 4.45 6.07 8.37 8.33

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.79 8.33 9.14 9.33 9.13

Gemina Laboratories Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $9.13 Mil mean?
Gemina Laboratories (GLABF) has a Common Stock of $9.13 Mil as of Oct. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Common Stock too high?
Gemina Laboratories' current Common Stock is $9.13 Mil.
How does Gemina Laboratories' Common Stock compare to VRTX and REGN?
Gemina Laboratories' Common Stock of $9.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current Common Stock is $9.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Common Stock of $9.13 Mil. The current Common Stock is $9.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Common Stock is $9.13 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.